Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05931939
Other study ID # Ileal interposition
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 1, 2023
Est. completion date May 1, 2026

Study information

Verified date April 2024
Source Rio de Janeiro State University
Contact Luiz Guilherme G Kraemer-Aguiar, PhD
Phone +55 21 23340703
Email lgkraemeraguiar@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators will study the Ileal interposition to the treatment of weight regain after Roux-en-Y gastric bypass, assessing weight loss, body composition, quality of life, metabolic biomarkers, inflammatory biomarkers, and incretin hormones


Description:

This prospective, controlled, randomized intervention study will investigate the Ileal interposition to the treatment of weight regain after Roux-en-Y gastric bypass, assessing weight loss, body composition, health-related quality of life, metabolic biomarkers, inflammatory biomarkers, and incretin hormones. The participants will also be assessed for alcohol abuse, depressive symptoms, level of physical activity, eating disorder symptoms, and dumping syndrome.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date May 1, 2026
Est. primary completion date April 1, 2026
Accepts healthy volunteers No
Gender All
Age group 21 Years to 60 Years
Eligibility Inclusion Criteria: - Patients submitted to initial laparoscopic after initial Roux-en-Y gastric bypass for at least 3 years - Loss of excess weight between 60 to 80% - Rate of weight regain =60% - Body mass index = 40 kg/m2 or = 35 kg/m2, with at least 2 comorbidities associated with obesity - Present a previous evaluation by the multidisciplinary team with a favorable opinion of the revision surgery. Exclusion Criteria: - Active chemical dependency on alcohol and/or illicit drugs - Severe psychotic or depressive disorder or history of suicide attempts in the last 12 months - Eating behavior disorder (uncontrolled) - Secondary causes of obesity - Pregnancy - Severe organ failure - Active neoplastic - Infectious or inflammatory disease - Severe coagulopathy - High anesthetic-surgical risk - Intellectual inability - Lack of preoperative follow-up

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Ileal Interposition
Bariatric surgery by laparoscopic Ileal Interposition
Traditional surgical technique
Bariatric surgery by laparoscopic traditional technique

Locations

Country Name City State
Brazil State University of Rio de Janeiro Rio de Janeiro

Sponsors (1)

Lead Sponsor Collaborator
Rio de Janeiro State University

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes of weight loss of participants after Ileal interposition surgery as measured by weight in kilograms Weight loss will be obtained as the difference between preoperative weight and minimum postoperative weight in kilograms Change from baseline and after 6 months post-surgery
Primary Changes of Health-related quality of life of participants after Ileal interposition surgery as reported by 36-Item Short-Form Health Survey questionnaire Health-related quality of life will be assessed using the 36-Item Short-Form Health Survey questionnaire Change from Baseline and after 6 months post-surgery
Secondary Changes of weight loss of participants after Ileal interposition surgery as measured by weight in kilograms Weight loss will be obtained as the difference between preoperative weight and minimum Change from baseline and after 3, 6, and 12 months post-surgery
Secondary Change of body composition of participants after Ileal interposition surgery as measured by lean and fat mass in kilograms Body composition will be assessed through dual X-ray absorptiometry (DXA) Change from baseline and after 6 and 12 months post-surgery
Secondary Change of metabolic profile of participants after Ileal interposition surgery as assessed by serum levels of glucose and insulin Blood sample collection will include serum levels of glucose and insulin Change from baseline and after 6 and 12 months post-surgery
Secondary Change of inflammatory biomarkers and incretin hormones of participants after Ileal interposition surgery as assessed by serum levels of tumor necrosis factor-alpha, interleukin-6, ghrelin, and glucagon-like peptide-1. Blood sample collection will include serum levels of tumor necrosis factor-alpha, interleukin-6, ghrelin, and glucagon-like peptide-1. Change from baseline and after 6 months post-surgery
Secondary Changes in alcohol abuse of participants after Ileal interposition surgery as reported by Alcohol Use Disorders Identification Test Alcohol abuse will be assessed using the Alcohol Use Disorders Identification Test Change from baseline and after 6 and 12 months post-surgery
Secondary Changes in depressive symptoms of participants after Ileal interposition surgery as reported by Beck Depression Inventory Depressive symptoms will be assessed using the Beck Depression Inventory questionnaire Change from baseline and after 6 and 12 months post-surgery
Secondary Changes in the level of physical activity of participants after Ileal interposition surgery as reported by the International Physical Activity Questionnaire Levels of physical activity will be assessed using the International Physical Activity Questionnaire Change from baseline and after 6 and 12 months post-surgery
Secondary Changes in the eating disorder symptoms of participants after Ileal interposition surgery as reported by the Eating Disorder Examination Questionnaire Eating disorder symptoms will be assessed using the Eating Disorder Examination Questionnaire Change from baseline and after 6 and 12 months post-surgery
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2